||5R24CA088282-05 Interpret this number
||Icahn School Of Medicine At Mount Sinai
||Biostatistical Core for Cancer Research
DESCRIPTION (provided by applicant):
New directions in cancer research are leading investigators to consider
increasingly complex theories and methodologies for studying cancer etiology,
progression, treatment, and prevention. Especially important is the
recognition of psychosocial, environmental, and genetic factors. The
integration of such factors in cancer research requires increased
sophistication in biostatistical theory and methods. The goal of the proposed
biostatistical core is to insure that cancer center researchers have access to
statistical expertise in the design of studies and in the analysis of data
arising from them. The specific aims are to: 1) Develop a shared resource in
biostatistical consultation (in study design and statistical analysis); 2)
Provide educational opportunities in biostatistical methods (through a
didactic course in biostatistical methods, an ongoing research seminar/journal
club, and quarterly workshops/symposia); and 3) Identify areas for the
development of new statistical methods. The Core will be available to all
Cancer Center faculty and trainees. Core members will include biostatisticians
with established track records (through prior collaborations with Cancer
Center researchers) in the application of biostatistical methods in basic
science and clinical medicine. A policy of prioritization of requests for
usage of the Core has been developed. Mechanisms will be established to
document all activity by Core members, and a computerized reporting system
will generate monthly and quarterly summary reports of Core activity to assist
the Facility Leader and Advisory Committee in their review of facility
Comparison of statistical models for analyzing genotype, inferred haplotype, and molecular haplotype data.
, Chen J.
, Wetmur J.G.
Molecular genetics and metabolism, 2006 Nov; 89(3), p. 270-3.
N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma.
, Guttman M.
, Jaffer S.
, Qiao R.
, Keren R.
, Triana A.
, Li M.
, Godbold J.
, Bleiweiss I.J.
, Hazan R.B.
Breast cancer research and treatment, 2005 Dec; 94(3), p. 225-35.